Prelude Therapeutics Incorporated PRLD
3.23 USD -0.02 (-0.77%)
Regular-session close
3.23 0.00 0.00%
After hours · Nov 20, 4:01 PM ET
3.17 Day range 3.30
1.30 52-week range 6.83
- YTD
- +11.38%
- 1 year
- +101.87%
Benzinga news
benzinga.com HC Wainwright & Co. Reiterates Buy on Prelude Therapeutics, Maintains $8 Price Target HC Wainwright & Co. analyst Robert Burns reiterates Prelude Therapeutics (NASDAQ:PRLD) with a Buy and maintains $8 price target.
benzinga.com Prelude Therapeutics Q3 EPS $(0.12) Misses $0.04 Estimate, Sales $5.647M Miss $29.000M Estimate Prelude Therapeutics (NASDAQ:PRLD) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $0.04 by 400 percent. This is a 53.85 percent increase over losses of…
